SpotitEarly
SpotitEarly
Scent-based multi-cancer early detection screening test using AI and bio-detectors.
About
SpotitEarly offers a single at-home breath test for pre-screening multiple cancer types, including breast, colorectal, lung, and prostate. This non-invasive, accessible test leverages the science of Volatile Organic Compounds (VOCs) in exhaled breath to detect early-stage cancer. The company aims to increase cancer screening adoption by providing an affordable and convenient solution for individuals.
Key facts
At-a-glance profile data
- Website
- spotitearly.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 17
- Total funding
- $6M (Seed)
- Business model
- B2B
- Tags
- HealthcareHealthTechMedTechBiotechDrug Discovery
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 23 Jun 2022 | Seed | $6M | Hanaco Ventures |
Tech stack
Detected on spotitearly.com, last scanned 23 Sept 2026. Run your own scan
- Analytics
- Google Analytics 4, Google Tag Manager
- Observability
- Sentry
- Support
- HubSpot
- CMS / Builders
- Wix
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has SpotitEarly raised?
SpotitEarly has raised a total of $6M in funding. The most recent round on record is Seed.
How many employees does SpotitEarly have?
SpotitEarly has approximately 17 people on record.